Point of View Archives

Leading digital health investors and venture firms shaping the global healthtech ecosystem in 2025

Who has the Golden Checkbook: Inside the 50 Core Investors Re-Wiring Global Digital Health (2025)

The HT50 Core Investors 2025 report reveals the 50 investors shaping global digital health—across stages, regions and themes. Drawing on HealthTech Alpha…

From Vision to Global Impact: Galen Growth Turns 10

In November 2015, five founders — Julien de Salaberry, Nawal Roy, Snehal Patel, Ronald Ling and Jeremy Sun — came together in…

Who is really winning pharma’s digital health innovation race in 2025?

Galen Growth’s 2025 Pharmaceutical Digital Health Innovation Index ranks the 25 most active global pharma companies on how effectively they embed digital…

The Great Remote Patient Monitoring Reckoning: Why UnitedHealthcare’s Policy Change Demands a Systemic Digital Health Reset

UnitedHealthcare’s rollback of remote patient monitoring coverage is a pivotal market signal exposing the unsustainable economics of CPT-dependent RPM companies. Beyond the…

TrumpRx Drug Price Mandate Disrupts Pharma’s Direct-to-Patient (DTP) Evolution: 3 Key Hypotheses

Researchers using AI technology to accelerate digital clinical trials under new UK and FDA regulations.

Smart Trials, Swift Cures: How Regulators are Contributing to the Digital Transformation of Clinical Trials

Regulators are accelerating the digital transformation of clinical trials. The UK’s AI-driven approval reforms and the FDA’s digital health guidance signal a…

Clearing the Bottleneck: How Digital Innovation Is Re-Engineering Clinical Trials

TL;DR — Why This Matters Clinical trials have become the biggest bottleneck in global drug development, consuming over half of all R&D…

Beyond Funding: Evidence and Partnerships Give DiMe Seal Ventures the Edge

In the fast-paced world of digital health, credibility, validation, and trust are the key differentiators between ventures that thrive and those that…